Cann Group Ltd. (AU:CAN) has released an update.
Cann Group Limited has released an investor update, detailing the company’s growth plans, product portfolio, and market opportunities as part of its strategic development in the medicinal cannabis industry. The company anticipates sharing its fourth quarter activities and financial results in upcoming reports and will conduct a webinar to discuss these outcomes with investors. Cann Group is known for its innovative cannabis medicines and operates a cutting-edge cultivation and manufacturing facility in Victoria, Australia.
For further insights into AU:CAN stock, check out TipRanks’ Stock Analysis page.
